Vera Therapeutics, Inc. (VERA) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$315.47M | -88.7% |
| 2024 | -$167.17M | -63.9% |
| 2023 | -$102.01M | -12.2% |
| 2022 | -$90.90M | -164.2% |
| 2021 | -$34.40M | +34.1% |
| 2020 | -$52.24M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$315.47M | -88.7% |
| 2024 | -$167.17M | -63.9% |
| 2023 | -$102.01M | -12.2% |
| 2022 | -$90.90M | -164.2% |
| 2021 | -$34.40M | +34.1% |
| 2020 | -$52.24M | — |